| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |